Currently out of the existing stock ratings of Felipe Ucros, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).

Felipe Ucros

Work Performance Price Targets & Ratings Chart

Analyst Felipe Ucros, currently employed at SCOTIABANK, carries an average stock price target met ratio of 50% that have a potential upside of 37.82% achieved within 533 days.

Felipe Ucros’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Consumer Defensive sector.

Most recent stock forecast was given on KOF, Coca-Cola Femsa SAB de CV ADR at 29-Apr-2025.

Wall Street Analyst Felipe Ucros

Analyst best performing recommendations are on KOF (COCA-COLA FEMSA SAB DE CV ADR).
The best stock recommendation documented was for KOF (COCA-COLA FEMSA SAB DE CV ADR) at 7/27/2021. The price target of $61 was fulfilled within 533 days with a profit of $16.74 (37.82%) receiving and performance score of 0.71.

Average potential price target upside

CCU Compania Cervecerias Unidas SA ADR KOF Coca-Cola Femsa SAB de CV ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Apr-2024

$10

$-0.59 (-5.57%)

$14

17 days ago
(21-Sep-2026)

4/6 (66.67%)

$-1.11 (-9.99%)

264

Sell Since 02-Feb-2026

$13

$2.41 (22.76%)

$14

1 months 7 days ago
(31-Aug-2026)

5/10 (50%)

$1.22 (10.36%)

49

Sell Since 12-Nov-2024

$10

$-1.39 (-12.20%)

1 years 27 days ago
(11-Sep-2025)

4/8 (50%)

$-1.94 (-16.25%)

198

Hold Since 20-Dec-2019

$17

$6.41 (60.53%)

$19

4 years 5 months 12 days ago
(26-Apr-2022)

0/3 (0%)

$5.22 (44.31%)

$25

$14.41 (136.07%)

$21

9 years 5 months 26 days ago
(12-Apr-2017)

1/2 (50%)

$7.81 (45.43%)

1009

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Felipe Ucros?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?